BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1240884)

  • 1. [Diagnosis of pregnancy before the menstrual period is delayed. Interest of the determination of plasma chorionic gonadotropin (HCG) in fertility disorders].
    Chartier M; Barrat J; Michelon B; Soldat MC
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):927-37. PubMed ID: 1240884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of human chorionic gonadotropin during the normal menstrual cycle.
    Cole LA; Gutierrez JM
    J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion and excretion of human chorionic gonadotropin during early pregnancy.
    Lohstroh PN; Overstreet JW; Stewart DR; Nakajima ST; Cragun JR; Boyers SP; Lasley BL
    Fertil Steril; 2005 Apr; 83(4):1000-11. PubMed ID: 15820813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of natural conceptual cycles occurring in a prospective study of sex preselection: fertility awareness symptoms, hormone levels, sperm survival, and pregnancy outcome.
    France JT; Graham FM; Gosling L; Hair P; Knox BS
    Int J Fertil; 1992; 37(4):244-55. PubMed ID: 1354212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
    Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
    Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of human chorionic gonadotropin for pregnancy testing.
    Feldkamp CS; Pfeffer WH
    Henry Ford Hosp Med J; 1982; 30(4):207-13. PubMed ID: 7169378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotropin in intrauterine device users.
    Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
    Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
    Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
    Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of GnRH analogue (buserelin) or hCG (Chorulon) on Day 12 of pregnancy on ovarian function, plasma hormone concentrations, conceptus growth and placentation in ewes and ewe lambs.
    Khan TH; Beck NF; Khalid M
    Anim Reprod Sci; 2007 Dec; 102(3-4):247-57. PubMed ID: 17174489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
    J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine insemination results in couples requiring extended semen transport time.
    Randall GW; Gantt PA
    Int J Fertil Womens Med; 2007; 52(1):28-34. PubMed ID: 17987885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancies without corpus luteum rescue.
    Naaktgeboren N; Devroey P; Wisanto A; Van Steirteghem AC
    Ann Biol Clin (Paris); 1987; 45(4):456-9. PubMed ID: 3674549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies.
    Odell WD; Ross GT; Rayford PL
    J Clin Invest; 1967 Feb; 46(2):248-55. PubMed ID: 6018762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.